Skip to main content
Premium Trial:

Request an Annual Quote

Hit Lists

Premium

1 For GT’s first anniversary we look back on our last 12 issues to see who in the industry earned the most mentions. Sure, it may say more about our coverage than anything else, but nevertheless, here are the GT darlings by number of issues mentioned:

 

10 Craig Venter

7 Francis Collins

Lee Hood

5 Ewan Birney

Eric Lander

Steve Lincoln

George Rathmann

4 Dan Joy

Jim Kent

Chris Marcazzo

2 In a fast-paced industry such as ours, fashions come and go. Here are the ins and outs of trends since GT’s inaugural issue:

Out In

Selling tools Drug discovery

IPOs Private funding

Startups Consolidation

SNPs Haplotypes

100,000 genes 30,000 genes

PE Applera

Genomics Proteomics

3 IPOs that did IPOs that didn’t

Brucker Daltonics Amersham Pharmacia

Ciphergen Biotech

Compugen Athersys

Genomica DoubleTwist

InforMax Genometrix

Third Wave NetGenics

4 Going, going…gone. These companies were swallowed up or shut their doors in the last 12 months:

Arcaris (acquired by Deltagen)

Artemis Pharmaceuticals (acquired by Exelixis)

Aurora Biosciences (acquired Vertex)

Axys Pharmaceuticals (acquired by Celera)

Cellmark Diagnostics (acquired by Orchid BioSciences)

Coelacanth (acquired by Lexicon Genetics)

Empatheon (acquired by eBioinformatics, now Entigen)

Gemini Genomics (acquired by Sequenom)

Genometrix (shut down)

GenomicFX (shut down)

Momentum Healthcare (acquired by Cellomics)

Neomorphic (acquired by Affymetrix)

Oxford Molecular (disbanded and software division acquired by Pharmacopeia)

 

Packard BioScience (acquired by PerkinElmer)

PanVera (acquired by Aurora Biosciences)

Principia Pharmaceutical (acquired by Human Genome Sciences)

Prospect Genomics (acquired by Structural GenomiX)

Proteome (aquired by Incyte)

Rosetta Inpharmatics (acquired by Merck)

Sawady (acquired by Qiagen)

Structure Function Genomics (acquired by GeneFormatics)

Synthetic Genetics (acquired by Epoch Biosciences)

Trega Biosciences (acquired by Lion Bioscience)

Xenometrix (acquired by Discovery PartnerInternational)

 

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.